Belgian biotech Galapagos is mixing things up again via a plan to split in two, separating its innovative medicines and cell therapy businesses, which will result in the loss of around 300 jobs or ...

A digital therapy that could reduce the severity of chronic tic disorders like Tourette syndrome has been recommended for use by the NHS for the first time. The technology, known as ORBIT (Online ...

The FDA issued approvals for Pfizer and Moderna's 2026 COVID-19 vaccines on Thursday, but is recommending them for the same ...

Developing new drugs and therapies is a contact sport for research sites. Investigators are on the frontlines, meeting and ...

Sword Health, a digital therapeutics company that started in the physical therapy space, has acquired digital mental health ...

Lantheus Holdings, Inc., a Bedford, Massachusetts-headquartered radiopharmaceutical-focused company, announced on 14 th ...

The US FDA has green lit ViiV Healthcare’s Tivicay PD (dolutegravir) for the treatment of HIV-1 in children weighing at least ...

Pharmaceutical portfolio decision-making is facing structural pressure. Patent expirations, rising development costs, ...

Cambridge, UK-based Neurocrine Biosciences - partnered with Japan’s Nxera Pharma - has announced it has received IND ...

Medical technology company Boston Scientific became the target of a cyberattack this week, which disrupted some of its IT ...

Roche’s Genentech has agreed a deal worth up to $2.3 billion to develop and sell Hanmi Pharmaceutical’s experimental obesity ...